Adar1 Capital Management, LLC Biocryst Pharmaceuticals Inc Transaction History

Adar1 Capital Management, LLC

  • $1.06 Trillion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
SELL
$7.06 - $9.39 $176,500 - $234,750
-25,000 Reduced 71.43%
10,000 $75 Million
Q3 2024

Nov 14, 2024
BUY
$6.41 - $8.69 $35,896 - $48,664
5,600 Added 19.05%
35,000 $266 Million
Q2 2024

Aug 13, 2024
BUY
$4.13 - $6.79 $121,422 - $199,626
29,400 New
29,400 $182 Million

Others Institutions Holding BCRX

# of Institutions
310
Shares Held
200M
Call Options Held
640K
Put Options Held
507K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.32B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email